Role of commensal gut bacteria in inflammatory bowel diseases

Gut Microbes

Volumn 3, Issue 6, 2012, Pages 544-555

  Loh, Gunnar ^a   Blaut, Michael ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Aiec; Crohn disease (cd); Escherichia coli; Faecalibacterium prausnitzii; Inflammatory bowel disease (ibd); Intestinal microbiota; Ulcerative colitis (uc)

Indexed keywords

ANTIBIOTIC AGENT; CASPASE RECRUITMENT DOMAIN PROTEIN 15; GAMMA INTERFERON; GENTAMICIN; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; METRONIDAZOLE; OUTER MEMBRANE PROTEIN A; RAG2 PROTEIN; RNA 16S; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CELL DIVISION; CELL SURVIVAL; COLITIS; COLON BIOPSY; COLON RESECTION; CROHN DISEASE; CYTOKINE PRODUCTION; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE COURSE; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; FLUORESCENCE IN SITU HYBRIDIZATION; GENE SEQUENCE; HUMAN; INTESTINE FLORA; MICROBIAL COMMUNITY; MOLECULAR MECHANICS; NONHUMAN; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; ULCERATIVE COLITIS;

ANIMALS; BACTERIA; BIOTA; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; METAGENOME; MODELS, ANIMAL;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; FAECALIBACTERIUM PRAUSNITZII; NEGIBACTERIA; POSIBACTERIA;

EID: 84868526965     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.22156     Document Type: Article

References (71)

1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369:1641-57; PMID:17499606; http://dx.doi.org/10.1016/S0140-6736(07)60751-X.
2. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142:46-54, e42, quiz e30; PMID:22001864; http://dx.doi.org/10.1053/j.gastro.2011.10.001.
3. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006; 3:390-407; PMID:16819502; http://dx.doi.org/10.1038/ncpgasthep0528.
4. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010; 28:573-621; PMID:20192811; http://dx.doi.org/10.1146/annurevimmunol-030409-101225.
5. Rogler G. Interaction between susceptibility and environment: examples from the digestive tract. Dig Dis 2011; 29:136-43; PMID:21734377; http://dx.doi.org/10.1159/000323876.
6. Thompson AI, Lees CW. Genetics of ulcerative colitis. Inflamm Bowel Dis 2011; 17:831-48; PMID:21319274; http://dx.doi.org/10.1002/ibd.21375.
7. Feller M, Huwiler K, Stephan R, Altpeter E, Shang A, Furrer H, et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis 2007; 7:607-13; PMID:17714674; http://dx.doi.org/10.1016/S1473-3099(07)70211-6.
8. Packey CD, Sartor RB. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis 2009; 22:292-301; PMID:19352175; http://dx.doi.org/10.1097/QCO.0b013e32832a8a5d.
9. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin- 10-deficient mice. Infect Immun 1998; 66:5224-31; PMID:9784526.
10. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernández-Sueiro JL, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994; 180:2359-64; PMID:7964509; http://dx.doi.org/10.1084/jem.180.6.2359.
11. Swidsinski A, Loening-Baucke V, Vaneechoutte M, Doerffel Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 2008; 14:147-61; PMID:18050295; http://dx.doi.org/10.1002/ibd.20330.
12. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science 2005; 308:1635-8; PMID:15831718; http://dx.doi.org/10.1126/science.1110591.
13. Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM. Mucosaassociated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 2002; 68:3401-7; PMID:12089021; http://dx.doi.org/10.1128/AEM.68.7.3401-3407.2002.
14. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004; 53:685-93; PMID:15082587; http://dx.doi.org/10.1136/gut.2003.025403.
15. Nishikawa J, Kudo T, Sakata S, Benno Y, Sugiyama T. Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis. Scand J Gastroenterol 2009; 44:180-6; PMID:18825588; http://dx.doi.org/10.1080/00365520802433231.
16. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007; 104:13780-5; PMID:17699621; http://dx.doi.org/10.1073/pnas.0706625104.
17. Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, Chen H, et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2011; 17:179-84; PMID:20839241; http://dx.doi.org/10.1002/ibd.21339.
18. Andoh A, Sakata S, Koizumi Y, Mitsuyama K, Fujiyama Y, Benno Y. Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis. Inflamm Bowel Dis 2007; 13:955-62; PMID:17455205; http://dx.doi.org/10.1002/ibd.20151.
19. Andoh A, Kuzuoka H, Tsujikawa T, Nakamura S, Hirai F, Suzuki Y, et al. Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease. J Gastroenterol 2012; PMID:22576027; http://dx.doi.org/10.1007/s00535-012-0605-0.
20. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006; 55:205-11; PMID:16188921; http://dx.doi.org/10.1136/gut.2005.073817.
21. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al.; MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65; PMID:20203603; http://dx.doi.org/10.1038/nature08821.
22. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010; 139:1844-54, e1; PMID:20816835; http://dx.doi.org/10.1053/j.gastro.2010.08.049.
23. Holmes I, Harris K, Quince C. Dirichlet multinomial mixtures: generative models for microbial metagenomics. PLoS One 2012; 7:e30126; PMID:22319561; http://dx.doi.org/10.1371/journal.pone.0030126.
24. Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 2011; 11:7; PMID:21219646; http://dx.doi.org/10.1186/1471-2180-11-7.
25. Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011; 60:631-7; PMID:21209126; http://dx.doi.org/10.1136/gut.2010.223263.
26. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009; 15:1183-9; PMID:19235886; http://dx.doi.org/10.1002/ibd.20903.
27. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008; 105:16731-6; PMID:18936492; http://dx.doi.org/10.1073/pnas.0804812105.
28. Heimesaat MM, Bereswill S, Fischer A, Fuchs D, Struck D, Niebergall J, et al. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol 2006; 177:8785-95; PMID:17142781.
29. Heimesaat MM, Fischer A, Jahn HK, Niebergall J, Freudenberg M, Blaut M, et al. Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 2007; 56:941-8; PMID:17255219; http://dx.doi.org/10.1136/gut.2006.104497.
30. Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, Yantiss R, et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J 2007; 1:403-18; PMID:18043660; http://dx.doi.org/10.1038/ismej.2007.52.
31. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004; 127:80-93; PMID:15236175; http://dx.doi.org/10.1053/j.gastro.2004.03.054.
32. Martinez-Medina M, Aldeguer X, Lopez-Siles M, González-Huix F, López-Oliu C, Dahbi G, et al. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent- invasive E. coli (AIEC) in Crohn's disease. Inflamm Bowel Dis 2009; 15:872-82; PMID:19235912; http://dx.doi.org/10.1002/ibd.20860.
33. Sasaki M, Sitaraman SV, Babbin BA, Gerner-Smidt P, Ribot EM, Garrett N, et al. Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest 2007; 87:1042-54; PMID:17660846; http://dx.doi.org/10.1038/labinvest.3700661.
34. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998; 115:1405-13; PMID:9834268; http://dx.doi.org/10.1016/S0016-5085(98)70019-8.
35. Boudeau J, Glasser AL, Masseret E, Joly B, Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun 1999; 67:4499-509; PMID:10456892.
36. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127:412-21; PMID:15300573; http://dx.doi.org/10.1053/j.gastro.2004.04.061.
37. Miquel S, Peyretaillade E, Claret L, de Vallée A, Dossat C, Vacherie B, et al. Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82. PLoS One 2010; 5:5; PMID:20862302; http://dx.doi.org/10.1371/journal.pone.0012714.
38. Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, Allez M, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007; 117:1566-74; PMID:17525800; http://dx.doi.org/10.1172/JCI30504.
39. Chassaing B, Rolhion N, de Vallée A, Salim SY, Prorok-Hamon M, Neut C, et al. Crohn disease--associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae. J Clin Invest 2011; 121:966-75; PMID:21339647; http://dx.doi.org/10.1172/JCI44632.
40. Rolhion N, Barnich N, Bringer MA, Glasser AL, Ranc J, Hébuterne X, et al. Abnormally expressed ER stress response chaperone Gp96 in CD favours adherentinvasive Escherichia coli invasion. Gut 2010; 59:1355-62; PMID:20587550; http://dx.doi.org/10.1136/gut.2010.207456.
41. Lapaquette P, Glasser AL, Huett A, Xavier RJ, Darfeuille-Michaud A. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 2010; 12:99-113; PMID:19747213; http://dx.doi.org/10.1111/j.1462-5822.2009.01381.x.
42. Lapaquette P, Bringer MA, Darfeuille-Michaud A. Defects in autophagy favour adherent-invasive Escherichia coli persistence within macrophages leading to increased pro-inflammatory response. Cell Microbiol 2012; 14:791-807; PMID:22309232; http://dx.doi.org/10.1111/j.1462-5822.2012.01768.x.
43. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005; 43:3380-9; PMID:16000463; http://dx.doi.org/10.1128/JCM.43.7.3380-3389.2005.
44. Heimesaat MM, Fischer A, Siegmund B, Kupz A, Niebergall J, Fuchs D, et al. Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One 2007; 2:e662; PMID:17653282; http://dx.doi.org/10.1371/journal.pone.0000662.
45. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003; 52:237-42; PMID:12524406; http://dx.doi.org/10.1136/gut.52.2.237.
46. Kotlowski R, Bernstein CN, Sepehri S, Krause DO. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 2007; 56:669-75; PMID:17028128; http://dx.doi.org/10.1136/gut.2006.099796.
47. Petersen AM, Nielsen EM, Litrup E, Brynskov J, Mirsepasi H, Krogfelt KA. A phylogenetic group of Escherichia coli associated with active left-sided inflammatory bowel disease. BMC Microbiol 2009; 9:171; PMID:19695087; http://dx.doi.org/10.1186/1471-2180-9-171.
48. Wohlgemuth S, Haller D, Blaut M, Loh G. Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice. Environ Microbiol 2009; 11:1562-71; PMID:19245530; http://dx.doi.org/10.1111/j.1462-2920.2009.01883.x.
49. Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, Donermeyer DL, et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 2011; 9:390-403; PMID:21575910; http://dx.doi.org/10.1016/j.chom.2011.04.009.
50. Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010; 8:292-300; PMID:20833380; http://dx.doi.org/10.1016/j.chom.2010.08.004.
51. Johansson ME, Larsson JM, Hansson GC. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4659-65; PMID:20615996; http://dx.doi.org/10.1073/pnas.1006451107.
52. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 2008; 105:15064-9; PMID:18806221; http://dx.doi.org/10.1073/pnas.0803124105.
53. Atuma C, Strugala V, Allen A, Holm L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol 2001; 280:G922-9; PMID:11292601.
54. Petersson J, Schreiber O, Hansson GC, Gendler SJ, Velcich A, Lundberg JO, et al. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 2011; 300:G327-33; PMID:21109593; http://dx.doi.org/10.1152/ajpgi.00422.2010.
55. Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4607-14; PMID:20826446; http://dx.doi.org/10.1073/pnas.1000092107.
56. Erridge C, Duncan SH, Bereswill S, Heimesaat MM. The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS One 2010; 5:e9125; PMID:20161736; http://dx.doi.org/10.1371/journal.pone.0009125.
57. Carvalho FA, Barnich N, Sauvanet P, Darcha C, Gelot A, Darfeuille-Michaud A. Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin. Inflamm Bowel Dis 2008; 14:1051-60; PMID:18338780; http://dx.doi.org/10.1002/ibd.20423.
58. Ivison SM, Himmel ME, Hardenberg G, Wark PA, Kifayet A, Levings MK, et al. TLR5 is not required for flagellin-mediated exacerbation of DSS colitis. Inflamm Bowel Dis 2010; 16:401-9; PMID:19774646.
59. Vijay-Kumar M, Sanders CJ, Taylor RT, Kumar A, Aitken JD, Sitaraman SV, et al. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest 2007; 117:3909-21; PMID:18008007.
60. Werner T, Wagner SJ, Martínez I, Walter J, Chang JS, Clavel T, et al. Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut 2011; 60:325-33; PMID:21076126; http://dx.doi.org/10.1136/gut.2010.216929.
61. Heuman R, Sjödahl R, Tobiasson P, Tagesson C. Decreased absorption of ingested unconjugated chenodeoxycholic acid in patients with Crohn's disease. Scand J Gastroenterol 1983; 18:23-6; PMID:6675175; http://dx.doi.org/10.3109/00365528309181553.
62. Nyhlin H, Merrick MV, Eastwood MA. Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT. Gut 1994; 35:90-3; PMID:8307458; http://dx.doi.org/10.1136/gut.35.1.90.
63. Ejderhamn J, Rafter JJ, Strandvik B. Faecal bile acid excretion in children with inflammatory bowel disease. Gut 1991; 32:1346-51; PMID:1752466; http://dx.doi.org/10.1136/gut.32.11.1346.
64. Kruis W, Kalek HD, Stellaard F, Paumgartner G. Altered fecal bile acid pattern in patients with inflammatory bowel disease. Digestion 1986; 35:189-98; PMID:3817328; http://dx.doi.org/10.1159/000199367.
65. Binder HJ, Filburn B, Floch M. Bile acid inhibition of intestinal anaerobic organisms. Am J Clin Nutr 1975; 28:119-25; PMID:234670.
66. Wohlgemuth S, Keller S, Kertscher R, Stadion M, Haller D, Kisling S, et al. Intestinal steroid profiles and microbiota composition in colitic mice. Gut Microbes 2011; 2:159-66; PMID:21869607; http://dx.doi.org/10.4161/gmic.2.3.16104.
67. Keshavarzian A, Banan A, Farhadi A, Komanduri S, Mutlu E, Zhang Y, et al. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 2003; 52:720-8; PMID:12692059; http://dx.doi.org/10.1136/gut.52.5.720.
68. Patwa LG, Fan TJ, Tchaptchet S, Liu Y, Lussier YA, Sartor RB, et al. Chronic intestinal inflammation induces stress-response genes in commensal Escherichia coli. Gastroenterology 2011; 141:1842-51, e1-10; PMID:21726510; http://dx.doi.org/10.1053/j.gastro.2011.06.064.
69. Schumann S, Alpert C, Engst W, Loh G, Blaut M. Dextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model. Appl Environ Microbiol 2012; 78:1513-22; PMID:22210207; http://dx.doi.org/10.1128/AEM.07340-11.
70. Becker N, Kunath J, Loh G, Blaut M. Human intestinal microbiota: characterization of a simplified and stable gnotobiotic rat model. Gut Microbes 2011; 2:25-33; PMID:21637015; http://dx.doi.org/10.4161/gmic.2.1.14651.
71. Greenblum S, Turnbaugh PJ, Borenstein E. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci U S A 2012; 109:594-9; PMID:22184244; http://dx.doi.org/10.1073/pnas.1116053109.